A small molecule Abl kinase inhibitor induces differentiation of Abelson virus-transformed pre-B cell lines

Nature Immunology

Volumn 4, Issue 1, 2003, Pages 31-37

  Muljo, Stefan A ^a,b   Schlissel, Mark S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; IMATINIB; IMMUNOGLOBULIN LIGHT CHAIN; INTERFERON REGULATORY FACTOR 4; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR IRF 4; TRANSCRIPTION FACTOR SPI B; UNCLASSIFIED DRUG;

ABELSON MURINE LEUKEMIA ONCOVIRUS; ANIMAL CELL; CONTROLLED STUDY; DNA MICROARRAY; ENHANCER REGION; GENE IDENTIFICATION; GENE INDUCTION; GENE REARRANGEMENT; GENETIC CODE; GENETIC TRANSCRIPTION; GERM LINE; IMMUNOGLOBULIN GENE; LYMPHOCYTE DIFFERENTIATION; LYMPHOID CELL LINE; MOUSE; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; VIRUS CELL TRANSFORMATION;

ABELSON MURINE LEUKEMIA VIRUS; ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; DNA; DNA-BINDING PROTEINS; ENZYME INHIBITORS; GENE EXPRESSION PROFILING; GENE REARRANGEMENT, B-LYMPHOCYTE, LIGHT CHAIN; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS V-ABL; PROTEIN-TYROSINE KINASES; PYRIMIDINES; TRANSCRIPTION FACTORS;

EID: 0037232230     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni870     Document Type: Review

References (57)

1. Hardy, R.R. et al. B-cell commitment, development and selection. Immunol. Rev. 175, 23-32 (2000).
2. Muljo, S.A & Schlissel, M.S. Pre-B and pre-T-cell receptors: conservation of strategies in regulating early lymphocyte development. Immunol. Rev. 175, 80-93 (2000).
3. Grawunder, U. et al. Down-regulation of RAG1 and RAG2 gene expression in preB cells after functional immunoglobulin heavy chain rearrangement. Immunity 3, 601-608 (1995).
4. H gene segments. Cell 40, 271-281 (1985).
5. Schlissel, M.S. & Baltimore, D. Activation of immunoglobulin κ gene rearrangement correlates with induction of germline κ gene transcription. Cell 58, 1001-1007 (1989).
6. Rosenberg, N., Baltimore, D. & Scher, C.D. In vitro transformation of lymphoid cells by Abelson murine leukemia virus. Proc. Natl. Acad. Sci. USA 72, 1932-1936 (1975).
7. Rosenberg, N. & Kincade, P.W. B-lineage differentiation in normal and transformed cells and the microenvironment that supports it. Curr. Opin. Immunol. 6, 203-211 (1994).
8. Jackson, P. & Baltimore, D. N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl. EMB0 J. 8, 449-456 (1989).
9. Pluk, H., Dorey, K. & Superti-Furga, G.Autoinhibition of c-Abl. Cell 108, 247-259 (2002).
10. Alt, F., Rosenberg, N., Lewis, S., Thomas, E. & Baltimore, D. Organization and reorganization of immunoglobulin genes in A-MULV-transformed cells: rearrangement of heavy but not light chain genes. Cell 27, 381-390 (1981).
11. Bendall, H.H., Sikes, M.L. & Oltz, E.M. Transcription factor NF-κB regulates Igλ light chain gene rearrangement. J. Immunol. 167, 264-269 (2001).
12. Schlissel, M.S., Corcoran, L.M. & Baltimore, D. Virus-transformed pre-B cells show ordered activation but not inactivation of immunoglobulin gene rearrangement and transcription. J. Exp. Med. 173, 711-720 (1991).
13. Klug, C.A. et al. The v-abl tyrosine kinase negatively regulates NF-κB/Rel factors and blocks κ gene transcription in pre-B lymphocytes. Genes Dev. 8, 678-687 (1994).
14. Chen, Y.Y., Wang, L.C., Huang, M.S. & Rosenberg, N. An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement. Genes Dev. 8, 688-697 (1994).
15. Schlissel, M., Constantinescu, A., Morrow, T., Baxter, M. & Peng, A. Double-strand signal sequence breaks in V(D)J recombination are blunt, 5′-phosphorylated, RAG-dependent, and cell cycle regulated. Genes Dev. 7, 2520-2532 (1993).
16. Stanhope-Baker, P., Hudson, K.M., Shaffer, A.L., Constantinescu, A. & Schlissel, M.S. Cell type-specific chromatin structure determines the targeting of V(D)J recombinase activity in vitro. Cell 85, 887-897 (1996).
17. Hoffmann, R., Seidl, T., Neeb, M., Rolink, A. & Melchers, F. Changes in gene expression profiles in developing B cells of murine bone marrow. Genome Res. 12, 98-111 (2002).
18. Chen, J., Ma, A., Young, F. & Alt, F.W. IL-2 receptor α chain expression during early B lymphocyte differentiation. Int Immunol 6, 1265-1268 (1994).
19. Rolink, A., Grawunder, U., Winkler, T.H., Karasuyama, H. & Melchers, F. IL-2 receptor α chain (CD25, TAC) expression defines a crucial stage in pre-B cell development. Int. Immunol. 6, 1257-1264 (1994).
20. Zou, X., Lin, Y., Rudchenko, S. & Calame, K. Positive and negative regulation of c-Myc transcription. Curr. Top. Microbiol. Immunol. 224, 57-66 (1997).
21. Morrow, M.A., Lee. G., Gillis, S., Yancopoulos. G.D. & Alt, F.W. Interleukin-7 induces N-myc and c-myc expression in normal precursor B lymphocytes. Genes Dev. 6, 61-70 (1992).
22. Eisenbeis, C.F., Singh, H. & Storb, U. Pip, a novel IRF family member, is a lymphoid-specific, PU. I-dependent transcriptional activator. Genes Dev. 9, 1377-1387 (1995).
23. Shaffer, A.L, Peng, A. & Schlissel, M.S. In vivo occupancy of the κ light chain enhancers in primary pro- and pre-B cells: a model for κ locus activation. Immunity 6, 131-143 (1997).
24. Sheehy, A.M. & Schlissel, M.S. Overexpression of RelA causes GI arrest and apoptosis in a pro-B cell line. J. Biol. Chem. 274, 8708-8716 (1999).
25. Paddison, P.J. & Hannon, G.J. RNA interference:the new somatic cell genetics? Cancer Cell 2,17-23 (2002).
26. Grandori, C., Mac, J., Siebelt, F., Ayer, D.E. & Eisenman, R.N. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo. EMBO J. 15, 4344-4357 (1996).
27. Corcoran, A.E., Riddell, A., Krooshoop, D. & Venkitaraman, A.R. Impaired immunoglobulin gene rearrangement in mice lacking the IL-7 receptor. Nature 391, 904-907 (1998).
28. Marshall, A.J., Fleming, H.E., Wu, G.E. & Paige, C.J. Modulation of the IL-7 dose-response threshold during pro-B cell differentiation is dependent on pre-B cell receptor expression. J. Immunol. 161, 6038-6045 (1998).
29. + B cells can continue to rearrange κ and λ L chain gene loci. J. Exp. Med. 178, 1263-1270 (1993).
30. Banerjee, A. & Rothman, P. IL-7 reconstitutes multiple aspects of v-Abl-mediated signaling. J. Immunol. 161, 4611-4617 (1998).
31. Perkins, E.J. et al. Sensing of intermediates in V(D)J recombination by ATM. Genes Dev. 16, 159-164 (2002).
32. Brown, L. & McCarthy, N. DNA repair. A sense-abl response? Nature 387,450-451 (1997).
33. + stage of thymocyte differentiation in the absence of T cell receptor rearrangement. J. Exp. Med 183, 1923-1928 (1996).
34. Tybulewicz, V.L., Crawford, C.E., Jackson, P.K., Bronson, R.T. & Mulligan, R.C. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65, 1153-1163 (1991).
35. Schwartzberg, P.L. et al. Mice homozygous for the ablm I mutation show poor viability and depletion of selected B and T cell populations. Cell 65, 1165-1175 (1991).
36. Hardin, J.D. et al. Bone marrow B lymphocyte development in c-abl-deficient mice. Cell. Immunol. 165, 44-54 (1995).
37. Kruh, G.D. et al. A novel human gene closely related to the abl proto-oncogene. Science 234, 1545-1548 (1986).
38. Koleske, A.J. et al. Essential roles for the Abl and Arg tyrosine kinases in neurulation. Neuron 21, 1259-1272 (1998).
39. Druker, B.J. et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N. Engl. J. Med. 344, 1031-1037 (2001).
40. Rao, S., Matsumura, A., Yoon, J. & Simon, M.C. SPI-B activates transcription via a unique proline, serine, and threonine domain and exhibits DNA binding affinity differences from PU.I. J. Biol. Chem. 274, 11115-11124 (1999).
41. Su, G. H. et al. Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B. EMBO J. 16, 7118-7129 (1997).
42. Dahl, R., Ramirez-Bergeron, D.L., Rao, S. & Simon, M.C. Spi-B can functionally replace PU.I in myeloid but not lymphoid development. EMB0 J. 21, 2220-2230 (2002).
43. Scott, E.W., Simon, M.C., Anastasi, J. & Singh, H. Requirement of transcription factor PU.I in the development of multiple hematopoietic lineages. Science 265, 1573-1577 (1994).
44. Garrett-Sinha, L.A. et al. PU.I and Spi-B are required for normal B cell receptor-mediated signal transduction. Immunity 10, 399-408 (1999).
45. Matsuyama, T. et al. Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE). Nucleic Acids Res. 23, 2127-2136 (1995).
46. Pongubala, J.M. et al. PU.I recruits a second nuclear factor to a site important for immunoglobulin κ 3′ enhancer activity. Mol. Cell Biol. 12, 368-378 (1992).
47. Eisenbeis, C.F, Singh, H. & Storb, U. PU.I is a component of a multiprotein complex which binds an essential site in the murine immunoglobulin λ 2-4 enhancer. Mol. Cell Biol. 13, 6452-6461 (1993).
48. Brass, A.L., Zhu, A.Q. & Singh, H. Assembly requirements of PU.I -Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers. EMB0 J. 18, 977-991 (1999).
49. Mittrucker, H.W. et al. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275, 540-543 (1997).
50. κ, rearrangement. Immunity 4, 377-385 (1996).
51. Gorman, J.R. et al. The Igκ 3′ enhancer influences the ratio of Igκ versus Igλ B lymphocytes. Immunity 5, 241-252 (1996).
52. Lewis, S., Rosenberg, N., Alt, F. & Baltimore, D. Continuing κ-gene rearrangement in a cell line transformed by Abelson murine leukemia virus. Cell 30, 807-816 (1982).
53. Shinkai, Y. et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68, 855-867 (1992).
54. Eisen, M.B., Spellman, P.T., Brown, P.O. & Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA95, 14863-14868 (1998).
55. Grogan, J.L. et al. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity 14, 205-215 (2001).
56. Han, S. et al. V(D)J recombinase activity in a subset of germinal center B lymphocytes. Science 278, 301-305 (1997).
57. DeKoter, R.P., Lee, H.J. & Singh, H. PU.I Regulates expression of the interleukin-7 receptor in lymphoid progenitors. Immunity 16, 297-309 (2002).